Figure 10From: Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect Comparison between in vivo constructs (4 and 8 weeks) to in vitro for the quantitative RT-PCR analysis ( p  < 0.05). It determined the gene expression of collagen type II (A), aggrecan (B), and Sox 9 (C). Native isolated RNA from normal native cartilage.Back to article page